Quality standards for sample collection in coagulation testing. 2012

Giuseppe Lippi, and Gian Luca Salvagno, and Martina Montagnana, and Gabriel Lima-Oliveira, and Gian Cesare Guidi, and Emmanuel J Favaloro
Department of Pathology and Laboratory Medicine, Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy. glippi@ao.pr.it, ulippi@tin.it

Preanalytical activities, especially those directly connected with blood sample collection and handling, are the most vulnerable steps throughout the testing process. The receipt of unsuitable samples is commonplace in laboratory practice and represents a serious problem, given the reliability of test results can be adversely compromised following analysis of these specimens. The basic criteria for an appropriate and safe venipuncture are nearly identical to those used for collecting blood for clinical chemistry and immunochemistry testing, and entail proper patient identification, use of the correct technique, as well as appropriate devices and needles. There are, however, some peculiar aspects, which are deemed to be particularly critical when collecting quality specimens for clot-based tests, and these require clearer recognition. These include prevention of prolonged venous stasis, collection of nonhemolyzed specimens, order of draw, and appropriate filling and mixing of the primary collection tubes. All of these important preanalytical issues are discussed in this article, and evidence-based suggestions as well as recommendations on how to obtain a high-quality sample for coagulation testing are also illustrated. We have also performed an investigation aimed to identify variation of test results due to underfilling of primary blood tubes, and have identified a clinically significant bias in test results when tubes are drawn at less than 89% of total fill for activated partial thromboplastin time, less than 78% for fibrinogen, and less than 67% for coagulation factor VIII, whereas prothrombin time and activated protein C resistance remain relatively reliable even in tubes drawn at 67% of the nominal volume.

UI MeSH Term Description Entries
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D001800 Blood Specimen Collection The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc. Blood Specimen Collections,Collection, Blood Specimen,Collections, Blood Specimen,Specimen Collection, Blood,Specimen Collections, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013048 Specimen Handling Procedures for collecting, preserving, and transporting of specimens sufficiently stable to provide accurate and precise results suitable for clinical interpretation. Specimen Collection,Collection, Specimen,Collections, Specimen,Handling, Specimen,Handlings, Specimen,Specimen Collections,Specimen Handlings

Related Publications

Giuseppe Lippi, and Gian Luca Salvagno, and Martina Montagnana, and Gabriel Lima-Oliveira, and Gian Cesare Guidi, and Emmanuel J Favaloro
September 2012, Seminars in thrombosis and hemostasis,
Giuseppe Lippi, and Gian Luca Salvagno, and Martina Montagnana, and Gabriel Lima-Oliveira, and Gian Cesare Guidi, and Emmanuel J Favaloro
January 2000, JAMA,
Giuseppe Lippi, and Gian Luca Salvagno, and Martina Montagnana, and Gabriel Lima-Oliveira, and Gian Cesare Guidi, and Emmanuel J Favaloro
December 2020, Thrombosis research,
Giuseppe Lippi, and Gian Luca Salvagno, and Martina Montagnana, and Gabriel Lima-Oliveira, and Gian Cesare Guidi, and Emmanuel J Favaloro
January 2002, Annales de biologie clinique,
Giuseppe Lippi, and Gian Luca Salvagno, and Martina Montagnana, and Gabriel Lima-Oliveira, and Gian Cesare Guidi, and Emmanuel J Favaloro
November 1996, Rinsho byori. The Japanese journal of clinical pathology,
Giuseppe Lippi, and Gian Luca Salvagno, and Martina Montagnana, and Gabriel Lima-Oliveira, and Gian Cesare Guidi, and Emmanuel J Favaloro
October 2008, Seminars in thrombosis and hemostasis,
Giuseppe Lippi, and Gian Luca Salvagno, and Martina Montagnana, and Gabriel Lima-Oliveira, and Gian Cesare Guidi, and Emmanuel J Favaloro
May 2008, Genetics in medicine : official journal of the American College of Medical Genetics,
Giuseppe Lippi, and Gian Luca Salvagno, and Martina Montagnana, and Gabriel Lima-Oliveira, and Gian Cesare Guidi, and Emmanuel J Favaloro
April 2008, Journal of virological methods,
Giuseppe Lippi, and Gian Luca Salvagno, and Martina Montagnana, and Gabriel Lima-Oliveira, and Gian Cesare Guidi, and Emmanuel J Favaloro
November 1996, Rinsho byori. The Japanese journal of clinical pathology,
Giuseppe Lippi, and Gian Luca Salvagno, and Martina Montagnana, and Gabriel Lima-Oliveira, and Gian Cesare Guidi, and Emmanuel J Favaloro
November 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Copied contents to your clipboard!